Delivery Order SPE2DB22D1103-SPE2DB25FTEC1

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,351.39 firm-fixed-price delivery order is for the supply of 120 tablets of Mesalamine DR 1.2 GM, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of December 4, 2024 and was awarded on December 3, 2024. It is not associated with a set-aside program....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,322.21 fixed-price delivery order is for the supply of 120 tablets of Mesalamine DR 1.2 GM, a medication used to treat certain gastrointestinal conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF1KE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,764.86, is for the delivery of 180 tablets of 800 mg Mesalamine, a medication used to treat certain gastrointestinal conditions. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,264.50 firm fixed-price delivery order is for the supply of 120 capsules of Mesalamine ER 0.375 gram, a medication used to treat certain gastrointestinal conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,278.66, is for the delivery of 180 tablets of Mesalamine 800 mg delayed-release tablets, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $17,541.47, is for the delivery of Mesalamine 800 mg delayed-release tablets. This award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mesalamine delayed-release tablets. The contract, valued at $3,679.63, has a completion date of September 20, 2023 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.74 firm fixed-price delivery order is for the supply of Mesalamine DR 1.2 GM Tablet 120S, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen maintains a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.99 firm fixed-price delivery order is for the supply of 4,567,198,508 units of Mesalamine DR 1.2 GM tablets, a medication used to treat certain gastrointestinal conditions. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 800 mg delayed-release mesalamine tablets, a medication used to treat gastrointestinal conditions. The award has a ceiling value of $22,978.15 and a completion date of July 16, 2024. The contract is structured as a firm fixed-price delivery order, without any set-aside designation....
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTEC1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,419.32 firm fixed-price delivery order is for the supply of 180 tablets of 800 mg Mesalamine, a medication used to treat certain gastrointestinal conditions.

The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC, which runs through November 2026, covers critical medical commodities across multiple therapeutic areas.

This specific contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. The ultimate completion date for this delivery order is January 14, 2025.

Generated 5/21/25, 9:44 AM